Record Display for the EPA National Library Catalog

RECORD NUMBER: 23 OF 72

OLS Field Name OLS Field Data
Main Title Interim Reregistration Eligibility Decision (IRED) Propetamphos (Includes Fact Sheet).
CORP Author Environmental Protection Agency, Washington, DC. Office of Prevention, Pesticides and Toxic Substances.
Publisher Oct 2000
Year Published 2000
Report Number EPA/738/R-99/018;
Stock Number PB2001-101850
Additional Subjects Organiophosphates ; Pesticides ; Registration ; Chemical properties ; Toxicity ; US EPA ; Insecticides ; Safety standards ; Risk assessment ; Humans ; Exposure ; Environmental impacts ; Administrative procedures ; Environmental transport ; Animals ; Insect control ; Pollution regulations ; Propetamphos ; Reregistration ; Food Quality Protection Act(FQPA)
Holdings
Library Call Number Additional Info Location Last
Modified
Checkout
Status
NTIS  PB2001-101850 Most EPA libraries have a fiche copy filed under the call number shown. Check with individual libraries about paper copy. 02/27/2001
Collation 100p
Abstract
EPA has assessed the risks of propetamphos and reached an Interim Reregistration Eligibility Decision (IRED) for this organophosphate (OP) pesticide. Provided that the risk mitigation measures outlined in this document are adopted, propetamphos fits into its own 'risk cup', that is, its aggregate risks are within acceptable levels. Propetamphos is also eligible for reregistration, pending a full reassessment of the cumulative risk from all OPs. Propetamphos is an insecticide used indoors for the control of insects, such as ants, cockroaches, fleas and termites. Propetamphos residues in food and drinking water do not pose risk concerns. Additionally, risks are low to workers who mix, load, and apply propetamphos at commercial and residential use sites. There are also no environmental risk concerns. However, there are post-application risk concerns for adults, and especially children entering areas treated with propetamphos. With mitigation canceling all residential use, propetamphos fits into its own 'risk cup'. With other mitigation measures, propetamphos' worker risks also will be below levels of concern for reregistration.